Back to list

Prescription only

ALIOLAPARIB

Generic Name
Olaparib
Specification
150mg × 120 ເມັດ
Dosage Form
—
FDD Registration No.
09 L 1389/25
Valid until
2029-04-18

Prescription only — Information only — no online sales

Description

Ingredients
Olaparib 150mg
Indications
BRCA-mutated ovarian, breast, pancreatic and prostate cancer (PARP inhibitor, maintenance therapy)
Dosage & Administration
Oral administration
Description
ALIOLAPARIB, active ingredient Olaparib, tablet, registered in Lao PDR.

Related products

Aliivosidenib
Prescription only

Aliivosidenib

Generic Name:Ivosidenib

Specification:250mg × 60 ເມັດ

Oncology & Hematology

View Details
Osimitib
Prescription only

Osimitib

Generic Name:Osimertinib

Specification:80mg × 30 ເມັດ

Oncology & Hematology

View Details
ALIDABRAFENIB
Prescription only

ALIDABRAFENIB

Generic Name:Dabrafenib

Specification:75mg × 120 ແຄບຊູນ

Oncology & Hematology

View Details
Cabozan
Prescription only

Cabozan

Generic Name:Cabozantinib

Specification:20mg × 90 ແຄບຊູນ

Oncology & Hematology

View Details
Information only — no online salesDisclaimer & Terms02057111655

Information only — no online sales · Disclaimer & Terms